de Groot JF - Search Results

1

IDH mutation status and the development of venous thromboembolism in astrocytoma patients.

Mandel JJ, Youssef M, Yust-Katz S, Patel AJ, Jalali A, Li Z, Wu J, Ludmir EB, de Groot JF. Mandel JJ, et al. Among authors: de groot jf. J Neurol Sci. 2021 Aug 15;427:117538. doi: 10.1016/j.jns.2021.117538. Epub 2021 Jun 15. J Neurol Sci. 2021. PMID: 34146775

2

Pregnancy and glial brain tumors.

Yust-Katz S, de Groot JF, Liu D, Wu J, Yuan Y, Anderson MD, Conrad CA, Milbourne A, Gilbert MR, Armstrong TS. Yust-Katz S, et al. Among authors: de groot jf. Neuro Oncol. 2014 Sep;16(9):1289-94. doi: 10.1093/neuonc/nou019. Epub 2014 Mar 9. Neuro Oncol. 2014. PMID: 24615863 Free PMC article.

3

Survival outcome of early versus delayed bevacizumab treatment in patients with recurrent glioblastoma.

Hamza MA, Mandel JJ, Conrad CA, Gilbert MR, Yung WK, Puduvalli VK, DeGroot JF. Hamza MA, et al. J Neurooncol. 2014 Aug;119(1):135-40. doi: 10.1007/s11060-014-1460-z. Epub 2014 May 7. J Neurooncol. 2014. PMID: 24803001 Free PMC article.

4

Prolonged survival in adult neurofibromatosis type I patients with recurrent high-grade gliomas treated with bevacizumab.

Theeler BJ, Ellezam B, Yust-Katz S, Slopis JM, Loghin ME, de Groot JF. Theeler BJ, et al. Among authors: de groot jf. J Neurol. 2014 Aug;261(8):1559-64. doi: 10.1007/s00415-014-7292-0. Epub 2014 May 25. J Neurol. 2014. PMID: 24859329

5

Leptomeningeal dissemination in glioblastoma; an inspection of risk factors, treatment, and outcomes at a single institution.

Mandel JJ, Yust-Katz S, Cachia D, Wu J, Liu D, de Groot JF, Yung AW, Gilbert MR. Mandel JJ, et al. Among authors: de groot jf. J Neurooncol. 2014 Dec;120(3):597-605. doi: 10.1007/s11060-014-1592-1. Epub 2014 Aug 29. J Neurooncol. 2014. PMID: 25168214

6

Adult brainstem gliomas: Correlation of clinical and molecular features.

Theeler BJ, Ellezam B, Melguizo-Gavilanes I, de Groot JF, Mahajan A, Aldape KD, Bruner JM, Puduvalli VK. Theeler BJ, et al. Among authors: de groot jf. J Neurol Sci. 2015;353(1-2):92-7. doi: 10.1016/j.jns.2015.04.014. Epub 2015 Apr 18. J Neurol Sci. 2015. PMID: 25934342 Free PMC article.

7

Primary and secondary gliosarcomas: clinical, molecular and survival characteristics.

Cachia D, Kamiya-Matsuoka C, Mandel JJ, Olar A, Cykowski MD, Armstrong TS, Fuller GN, Gilbert MR, De Groot JF. Cachia D, et al. Among authors: de groot jf. J Neurooncol. 2015 Nov;125(2):401-10. doi: 10.1007/s11060-015-1930-y. Epub 2015 Sep 9. J Neurooncol. 2015. PMID: 26354773 Free PMC article.

8

Impact of IDH1 mutation status on outcome in clinical trials for recurrent glioblastoma.

Mandel JJ, Cachia D, Liu D, Wilson C, Aldape K, Fuller G, de Groot JF. Mandel JJ, et al. Among authors: de groot jf. J Neurooncol. 2016 Aug;129(1):147-54. doi: 10.1007/s11060-016-2157-2. Epub 2016 Jun 7. J Neurooncol. 2016. PMID: 27270908 Free PMC article.

9

Radiographic patterns of progression with associated outcomes after bevacizumab therapy in glioblastoma patients.

Cachia D, Elshafeey NA, Kamiya-Matsuoka C, Hatami M, Alfaro-Munoz KD, Mandel JJ, Colen R, DeGroot JF. Cachia D, et al. J Neurooncol. 2017 Oct;135(1):75-81. doi: 10.1007/s11060-017-2550-5. Epub 2017 Jul 12. J Neurooncol. 2017. PMID: 28702781

10

Inability of positive phase II clinical trials of investigational treatments to subsequently predict positive phase III clinical trials in glioblastoma.

Mandel JJ, Yust-Katz S, Patel AJ, Cachia D, Liu D, Park M, Yuan Y, Kent TA, de Groot JF. Mandel JJ, et al. Among authors: de groot jf. Neuro Oncol. 2018 Jan 10;20(1):113-122. doi: 10.1093/neuonc/nox144. Neuro Oncol. 2018. PMID: 29016865 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

201 results

Search Page

Filters